Licensing Resources for Veterans
An Online Resource for Skilled Immigrants
Office of Policy & Legislative Affairs
Construction Codes
Community and Health Systems
Corporations, Securities & Commercial Licensing Bureau.
Michigan Office of Administrative Hearings and Rules
Professional Licensing
Search is currently unavailable. Please try again later.
The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
The Prescription Drug & Opioid Abuse Commission, Opioid Prescribing Engagement Network (OPEN) and University of Michigan Injury Prevention Center partnered to offer acute pain recommendations for emergency and surgical departments as well as dentists. The recommendations are linked below:
The MAPS poster illustrates practitioner’s and pharmacist’s use of MAPS, and provides a visual display to individuals who intend to fraudulently obtain controlled substances, thereby deterring such fraudulent activity. Practitioners and pharmacists consistently deal with individuals who fraudulently attempt to obtain controlled substances, which wastes valuable resources for legitimate patients. The display of the MAPS poster is a proactive approach by practitioners and pharmacists to assist in the prevention of overprescribing and drug diversion, at a time when drug abuse is a major public health concern.
There are two poster options available for download:
Option 1 – MAPS Poster
MAPS Poster (8.5” x 11”)
MAPS Poster (11” x 17”)
Option 2 – MAPS Poster with the ability to customize by adding your facility’s Logo to the bottom-right
Customizable MAPS Poster (8.5” x 11”)
Customizable MAPS Poster (11” x 17”)
Please Note: If you have difficulty downloading either of the above files, please save the file as an Adobe PDF file to open and view/print from your computer.
The State of Michigan is covering the full cost of integration of MAPS into the clinical workflow of health systems, physician groups and pharmacies through at least September 30, 2025. Learn how to start the integration process.
If your question(s) pertain to the new opioid legislation, we encourage you to review the recently-released FAQs. Additional questions or concerns can be addressed by contacting MAPS.
